T 1360/24 (CNP variants/Ascendis) of 16.10.2025
- European Case Law Identifier
- ECLI:EP:BA:2025:T136024.20251016
- Date of decision
- 16 October 2025
- Case number
- T 1360/24
- Petition for review of
- -
- Application number
- 16192229.9
- IPC class
- A61P 19/00A61K 38/22C07K 14/58A61P 9/04A61P 9/10A61P 21/00A61K 47/60A61P 13/12A61P 9/00A61P 9/12A61P 19/08A61P 7/10
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Variants of C-type natriuretic peptide
- Applicant name
- BioMarin Pharmaceutical Inc.
- Opponent name
- Ascendis Pharma Growth Disorders A/S
Ascendis Pharma A/S - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 76(1)
- Keywords
- Divisional application - added subject-matter (yes)
- Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The decision under appeal is set aside.
The patent is revoked.